Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

COLLEGIUM PHARMACEUTICAL, INC.

(COLL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company focused on pain management. The Company's product portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone, and Nucynta ER and Nucynta IR (Nucynta Products), which are extended-release (ER) and immediate-release (IR) formulations of tapentadol. Xtampza ER is formulated using its abuse-deterrent technology platform, DETERx. Xtampza ER is for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. Nucynta ER is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment, including neuropathic pain associated with diabetic peripheral neuropathy in adults, and for which alternate treatment options are inadequate. Nucynta IR is indicated for the management of acute pain severe enough to require an opioid analgesic, and for which alternative treatments are inadequate in adults.

Number of employees : 234 people.
Sales per Business
20192020Delta
Pharmaceutical Products296.70100%310.02100% +4.49%
USD in Million
Sales per region
20192020Delta
United States296.70100%310.02100% +4.49%
USD in Million
Managers
Name Title Age Since
Joseph J. Ciaffoni President, Chief Executive Officer & Director 50 2018
Colleen Tupper Chief Financial Officer & Executive Vice President 45 2021
Scott Sudduth Executive Vice President-Technical Operations - 2021
Richard Malamut, Dr. Chief Medical Officer 61 -
Gino Santini Lead Independent Director 64 2015
John Gordon Freund, Dr. Independent Director 67 2014
Garen G. Bohlin Independent Director 73 2015
John A. Fallon, Dr. Independent Director 73 2016
Gwen A. Melincoff, Dr. Independent Director 69 2017
Rita Balice-Gordon, Dr. Independent Director 60 2020
Members of the board
Name Title Age Since
Michael Thomas Heffernan Chairman 56 2018
Gino Santini Lead Independent Director 64 2015
John Gordon Freund, Dr. Independent Director 67 2014
Garen G. Bohlin Independent Director 73 2015
John A. Fallon, Dr. Independent Director 73 2016
Joseph J. Ciaffoni President, Chief Executive Officer & Director 50 2018
Gwen A. Melincoff, Dr. Independent Director 69 2017
Rita Balice-Gordon, Dr. Independent Director 60 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 35,427,749 34,099,284 96.3% 859,040 2.4% 96.3%
Shareholders
NameEquities%
Janus Capital Management LLC 4,098,911 11.9%
Eventide Asset Management LLC 2,629,593 7.61%
Rubric Capital Management LP 2,606,500 7.54%
The Vanguard Group, Inc. 2,242,669 6.49%
Cadian Capital Management LP 2,060,284 5.96%
Camber Capital Management LP 2,000,000 5.79%
TPG Group Holdings (SBS) Advisors, Inc. 1,436,960 4.16%
HealthCor Management LP 1,426,300 4.13%
Renaissance Technologies LLC 1,304,997 3.78%
Franklin Advisers, Inc. 1,240,994 3.59%
Company contact information
Collegium Pharmaceutical, Inc.
100 Technology Center Drive
Suite 300
Stoughton, MA 02072

Phone : +1.781.713.3699
Fax : +1.781.828.4697
Web : http://www.collegiumpharma.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Collegium Pharmaceutical, Inc.
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
COLLEGIUM PHARMACEUTICAL, INC.-5.19%616
JOHNSON & JOHNSON-1.57%443 277
ROCHE HOLDING AG-7.91%306 143
PFIZER, INC.-10.23%297 538
ABBVIE INC.-0.86%237 303
ELI LILLY AND COMPANY-13.89%215 642
NOVO NORDISK A/S-15.89%213 450
MERCK & CO., INC.3.26%199 903
NOVARTIS AG-2.64%189 740
ASTRAZENECA PLC-2.27%177 586
BRISTOL-MYERS SQUIBB COMPANY-0.18%138 151
SANOFI3.79%130 219
AMGEN INC.-1.08%125 349
GLAXOSMITHKLINE PLC1.57%110 966
BAYER AG9.68%57 141
CHUGAI PHARMACEUTICAL CO., LTD-1.02%53 161
TAKEDA PHARMACEUTICAL COMPANY LIMITED5.45%45 060
DAIICHI SANKYO CO., LTD.-11.11%43 582
JIANGSU HENGRUI MEDICINE CO., LTD.-18.97%42 423
ASTELLAS PHARMA INC.0.72%30 528
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY-18.88%19 826